The New York Post e-Edition

First ‘postpartum’ pill

Brooke Steinberg

A first-of-its-kind pill for postpartum depression could be available to women in the US by August.

The drug, called Zuranolone, is now being reviewed by the Food and Drug Administration and could be approved by Aug. 6, said drugmakers Sage Therapeutics and Biogen.

The fast-acting antidepressant would be taken once a day for two weeks.

NEWS

en-us

2023-02-08T08:00:00.0000000Z

2023-02-08T08:00:00.0000000Z

https://nypost.pressreader.com/article/281526525213281

New York Post